SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
-11.36%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.05B
AUM Growth
+$1.05B
(-22%)
Cap. Flow
-$67.4M
Cap. Flow
% of AUM
-6.4%
Top 10 Holdings %
Top 10 Hldgs %
68.08%
Holding
76
New
16
Increased
8
Reduced
12
Closed
14
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$27.6M |
| 2 |
Merck
MRK
|
$17.2M |
| 3 |
Align Technology
ALGN
|
$8.09M |
| 4 |
Mirum Pharmaceuticals
MIRM
|
$5.86M |
| 5 |
Puma Biotechnology
PBYI
|
$5.39M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$18.8M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$17.1M |
| 3 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$14M |
| 4 |
Fate Therapeutics
FATE
|
$13.3M |
| 5 |
MacroGenics
MGNX
|
$12.8M |
Sector Composition
| 1 | Healthcare | 98.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDMN
26
DELISTED
Kadmon Holdings, Inc.
KDMN
| $6.4M | 0.59% |
1,526,178
-842,780
| -36% | -$3.53M |
|
|
CHMA
27
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $5.95M | 0.55% |
1,630,221
| – | – |
|
|
28
Mirum Pharmaceuticals
MIRM
$3.75B
| $5.86M | 0.54% |
+418,589
| New | +$5.86M |
|
29
Heron Therapeutics
HRTX
$204M
| $5.65M | 0.52% |
481,608
+431,108
| +854% | +$5.06M |
|
|
30
Puma Biotechnology
PBYI
$258M
| $5.39M | 0.5% |
+638,026
| New | +$5.39M |
|
31
Amicus Therapeutics
FOLD
$2.42B
| $4.86M | 0.45% |
525,530
+50,200
| +11% | +$464K |
|
32
Iterum Therapeutics
ITRM
$28.1M
| $4.68M | 0.43% |
1,726,514
| – | – |
|
33
Axsome Therapeutics
AXSM
$6.09B
| $4.3M | 0.4% |
+73,163
| New | +$4.3M |
|
34
AbbVie
ABBV
$374B
| $3.81M | 0.35% |
+50,000
| New | +$3.81M |
|
|
BPMC
35
DELISTED
Blueprint Medicines
BPMC
| $3.69M | 0.34% |
+63,100
| New | +$3.69M |
|
|
CALA
36
DELISTED
Calithera Biosciences, Inc
CALA
| $3.64M | 0.34% |
819,002
-639,819
| -44% | -$2.84M |
|
37
Q32 Bio
QTTB
$20.9M
| $3.58M | 0.33% |
230,663
+166,266
| +258% | +$2.58M |
|
|
AGTC
38
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $3.49M | 0.32% |
+1,062,615
| New | +$3.49M |
|
39
Akero Therapeutics
AKRO
$3.65B
| $3.15M | 0.29% |
+148,415
| New | +$3.15M |
|
|
ETTX
40
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $3.12M | 0.29% |
1,180,178
| – | – |
|
|
OTIC
41
DELISTED
Otonomy, Inc.
OTIC
| $2.99M | 0.28% |
1,515,629
| – | – |
|
42
TG Therapeutics
TGTX
$5.03B
| $2.71M | 0.25% |
275,305
-535,987
| -66% | -$5.27M |
|
|
CCXI
43
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.68M | 0.25% |
66,695
-310,249
| -82% | -$12.5M |
|
44
Rigel Pharmaceuticals
RIGL
$710M
| $2.26M | 0.21% |
+1,446,318
| New | +$2.26M |
|
45
Compugen
CGEN
$133M
| $2.18M | 0.2% |
+300,000
| New | +$2.18M |
|
|
SAGE
46
DELISTED
Sage Therapeutics
SAGE
| $2.14M | 0.2% |
+74,430
| New | +$2.14M |
|
47
Aclaris Therapeutics
ACRS
$223M
| $1.99M | 0.18% |
1,911,573
| – | – |
|
48
Zymeworks
ZYME
$1.07B
| $1.77M | 0.16% |
49,989
-57,563
| -54% | -$2.04M |
|
49
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.63M | 0.15% |
815,690
-1,335,474
| -62% | -$2.67M |
|
50
VYNE Therapeutics
VYNE
$8.09M
| $1.62M | 0.15% |
+604,829
| New | +$1.62M |
|